Crossmark

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

Crossref DOI link: https://doi.org/10.1186/s40425-019-0549-5

Published Online: 2019-03-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ménétrier-Caux, Christine https://orcid.org/0000-0003-4863-374X
Ray-Coquard, Isabelle

Blay, Jean-Yves

Caux, Christophe
Funding

Funding for this research was provided by:

Breast Cancer Research Foundation

INCa-DGOS (LYRICAN INCa-DGOS-Inserm_12563)

FUI AAP-10 DIVRESCUE (OSEO F1105032Z and Région Rhône-Alpes N° 1101030301)

INCa (2011-052 and 2013-208)

ANR (Labex DevWeCan ANR-10-LABX-0061)
License Information

Text and Data Mining valid from 2019-03-28
More Information

Article History

Received: 8 October 2018

Accepted: 27 February 2019

First Online: 28 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.